Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide <i>N</i>-Methyltransferase (NNMT) Display Cellular Activity
A recently discovered bisubstrate inhibitor of Nicotinamide <i>N</i>-methyltransferase (NNMT) was found to be highly potent in biochemical assays with a single digit nanomolar IC<sub>50</sub> value but lacking in cellular activity. We, here, report a prodrug strategy designed...
Main Authors: | Matthijs J. van Haren, Yongzhi Gao, Ned Buijs, Roberto Campagna, Davide Sartini, Monica Emanuelli, Lukasz Mateuszuk, Agnieszka Kij, Stefan Chlopicki, Pol Escudé Martinez de Castilla, Raymond Schiffelers, Nathaniel I. Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/9/1357 |
Similar Items
-
High stromal nicotinamide N‐methyltransferase (NNMT) indicates poor prognosis in colorectal cancer
by: Mengmeng Song, et al.
Published: (2020-03-01) -
Exosomal NNMT from peritoneum lavage fluid promotes peritoneal metastasis in gastric cancer
by: A‐Kao Zhu, et al.
Published: (2021-04-01) -
Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy
by: Xiao-Yu Li, et al.
Published: (2022-06-01) -
Nicotinamide N‐methyltransferase is related to MELF pattern invasion in endometrioid carcinoma
by: Shinichiro Tahara, et al.
Published: (2021-12-01) -
Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer
by: Jun Li, et al.
Published: (2021-01-01)